Inovio Pharmaceuticals Inc (INO) Stock Performance in the Last 52 Weeks

The closing price of Inovio Pharmaceuticals Inc (NASDAQ: INO) was $0.52 for the day, down -7.70% from the previous closing price of $0.56. In other words, the price has decreased by -$0.0434 from its previous closing price. On the day, 3793050 shares were traded. INO stock price reached its highest trading level at $0.5900 during the session, while it also had its lowest trading level at $0.4950.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Ratios:

Our analysis of INO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.00 and its Current Ratio is at 4.00. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.08.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 05 when Zoth Lota S. sold 5,700 shares for $0.56 per share. The transaction valued at 3,192 led to the insider holds 52,716 shares of the business.

Weiner David B. sold 5,833 shares of INO for $6,708 on Mar 13. The Director now owns 910,124 shares after completing the transaction at $1.15 per share. On Feb 27, another insider, Weiner David B., who serves as the Director of the company, sold 11,668 shares for $1.28 each. As a result, the insider received 14,935 and left with 904,291 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INO now has a Market Capitalization of 142.25M and an Enterprise Value of 4.58M. For the stock, the TTM Price-to-Sale (P/S) ratio is 167.20 while its Price-to-Book (P/B) ratio in mrq is 1.02. Its current Enterprise Value per Revenue stands at 5.36 whereas that against EBITDA is -0.03.

Stock Price History:

Over the past 52 weeks, INO has reached a high of $1.99, while it has fallen to a 52-week low of $0.32. The 50-Day Moving Average of the stock is 0.4048, while the 200-Day Moving Average is calculated to be 0.5372.

Shares Statistics:

INO traded an average of 3.66M shares per day over the past three months and 3M shares per day over the past ten days. A total of 272.99M shares are outstanding, with a floating share count of 268.63M. Insiders hold about 1.59% of the company’s shares, while institutions hold 20.48% stake in the company. Shares short for INO as of Dec 14, 2023 were 24.27M with a Short Ratio of 24.27M, compared to 25.95M on Nov 14, 2023. Therefore, it implies a Short% of Shares Outstanding of 8.89% and a Short% of Float of 8.96%.

Earnings Estimates

The firm’s stock currently is rated by 3 analysts. On average, analysts expect EPS of -$0.11 for the current quarter, with a high estimate of -$0.08 and a low estimate of -$0.15, while EPS last year was -$0.21. The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.09 and low estimates of -$0.09.

Analysts are recommending an EPS of between -$0.48 and -$0.57 for the fiscal current year, implying an average EPS of -$0.52. EPS for the following year is -$0.33, with 3 analysts recommending between -$0.23 and -$0.39.

Revenue Estimates

For the next quarter, 1 analysts are estimating revenue of $200k, an increase of 75.40% over than the figure of -$11.30% in the same quarter last year. There is a high estimate of $200k for the next quarter, whereas the lowest estimate is $200k.

A total of 3 analysts have provided revenue estimates for INO’s current fiscal year. The highest revenue estimate was $980k, while the lowest revenue estimate was $700k, resulting in an average revenue estimate of $830k. In the same quarter a year ago, actual revenue was $10.26M, down -91.90% from the average estimate.

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular